Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HurtSkurt is a consumer health and recovery company that sells wearable hot/cold therapy sleeves and related accessories for pain relief and injury recovery. Its products are designed to provide hands-free thermal therapy for areas such as the knee, ankle, shoulder, back, elbow, and head, with use cases including sprains, soreness, chronic pain, and post-surgical recovery. The company appears to operate primarily as a direct-to-consumer brand rather than a traditional biotech or pharmaceutical developer. HurtSkurt emphasizes reusable gel-based sleeves, comfort, style, and ease of use, and markets some products as HSA/FSA eligible. Based on available public information, the company is active and commercially focused, with no evidence of a drug development pipeline or clinical-stage therapeutic programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HurtSkurt.